451
Views
28
CrossRef citations to date
0
Altmetric
Original Research

Estimated impact of rotavirus vaccine on hospitalizations and deaths from rotavirus diarrhea among children <5 in Asia

, , , , , & show all
Pages 453-460 | Received 11 Sep 2017, Accepted 16 Feb 2018, Published online: 26 Feb 2018

References

  • Tate JE, Burton AH, Boschi-Pinto C, et al. Global, regional, and national estimates of rotavirus mortality in children <5 years of age, 2000–2013. Clin Infect Dis. 2016;62(Suppl 2):S96–S105.
  • Rotavirus vaccines. WHO position paper - January 2013. Wkly Epidemiol Rec. 2013;88(5):49–64.
  • Burnett E, Jonesteller CL, Tate JE, et al. Global impact of rotavirus vaccination on childhood hospitalizations and mortality from diarrhea. J Infect Dis. 2017;215(11):1666–1672.
  • Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354(1):11–22.
  • Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354(1):23–33.
  • Kirkwood CD, Ma LF, Carey ME, et al. The rotavirus vaccine development pipeline. Vaccine. 2017.
  • Bhandari N, Rongsen-Chandola T, Bavdekar A, et al. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet. 2014;383(9935):2136–2143.
  • Isanaka S, Guindo O, Langendorf C, et al. Efficacy of a low-cost, heat-stable oral rotavirus vaccine in Niger. N Engl J Med. 2017;376(12):1121–1130.
  • Fu C, He Q, Xu J, et al. Effectiveness of the Lanzhou lamb rotavirus vaccine against gastroenteritis among children. Vaccine. 2012;31(1):154–158.
  • Luan Le T, Trang NV, Phuong NM, et al. Development and characterization of candidate rotavirus vaccine strains derived from children with diarrhoea in Vietnam. Vaccine. 2009;27(Suppl 5):F130–F138.
  • Organization WH. Rotavirus vaccines: an update. Wkly Epidemiol Rec. 2009;84(51/52):533–537.
  • Rotavirus Vaccine Country Introductions: Maps and List. (Ed.^(Eds) (PATH). 2016 [cited 2017 Aug 10]. Available from: http://www.path.org/vaccineresources/details.php?i=2235
  • Tharmaphornpilas P, Jiamsiri S, Boonchaiya S, et al. Evaluating the first introduction of rotavirus vaccine in Thailand: moving from evidence to policy. Vaccine. 2017;35(5):796–801.
  • Dayrit E Philippines experience In: 12th International Rotavirus Symposium. (Ed.^(Eds). Melbourne, Australia; 2016.
  • Millennium Development Indicators: World and regional groupings. Ed.^(Eds) (United Nations Statistics Division). 2014 [cited 2017 Aug 10]. Available from: https://mdgs.un.org/unsd/mdg/Host.aspx?Content=Data/RegionalGroupings.htm
  • Levels & Trends in Child Mortality; Report 2015 Estimates Developed by the UN Inter-agency Group for Child Mortality Estimation. (Ed.^(Eds) (UNICEF United Nations Inter-agency Group for Child Mortality Estimation). 2015 [cited 2017 Aug 10]. Available from: http://data.unicef.org/corecode/uploads/document6/uploaded_pdfs/corecode/IGME-report-2015-child-mortality-final_236.pdf
  • World Bank Country and Lending Groups. Ed.^(Eds) (The World Bank). 2016 [cited 2017 Aug 10]. Available from: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups
  • Countries eligible for support. 2016 [cited 2017 Aug 10]. (Ed.^(Eds) (Gavi: the Vaccine Alliance). Available from: http://www.gavi.org/support/sustainability/countries-eligible-for-support
  • Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorpora-ting network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777–784.
  • Shah MP, Tate JE, Mwenda JM, et al. Estimated reductions in hospitalizations and deaths from childhood diarrhea following implementation of rotavirus vaccination in Africa. Expert Rev Vaccines. 2017;16(10):987–995.
  • Annual population by age groups- both sexes. (Ed.^(Eds) (United Nations Population Division). 2015 [cited 2017 Aug 10]. Available from: https://esa.un.org/unpd/wpp/Download/Standard/Population/
  • Third dose of diphtheria toxoid, tetanus toxoid, and pertussis vaccine. (Ed.^(Eds) (World Health Organization). 2016 [cited 2017 Aug 10]. Available from: http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tscoveragedtp3.html
  • Health Facts of Hong Kong 2017 Edition. (Ed.^(Eds) (The Government of Hong Kong Department of Health). 2017 [cited 2017 Aug 10]. Available from: http://www.dh.gov.hk/english/statistics/statistics_hs/files/Health_Statistics_pamphlet_E.pdf
  • At a glance: State of Palestine. (Ed.^(Eds) (UNICEF). 2013 [cited 2017 Aug 10]. Available from: https://www.unicef.org/infobycountry/oPt_statistics.html
  • Chan PK, Tam JS, Nelson EA, et al. Rotavirus infection in Hong Kong: epidemiology and estimates of disease burden. Epidemiol Infect. 1998;120(3):321–325.
  • Chiang GP, Nelson EA, Pang TJ, et al. Rotavirus incidence in hospitalised Hong Kong children: 1 July 1997 to 31 March 2011. Vaccine. 2014;32(15):1700–1706.
  • Nelson EA, Tam JS, Bresee JS, et al. Estimates of rotavirus disease burden in Hong Kong: hospital-based surveillance. J Infect Dis. 2005;192(Suppl 1):S71–S79.
  • Kawai K, O’Brien MA, Goveia MG, et al. Burden of rotavirus gastroenteritis and distribution of rotavirus strains in Asia: a systematic review. Vaccine. 2012;30(7):1244–1254.
  • Hsu VP, Abdul Rahman HB, Wong SL, et al. Estimates of the burden of rotavirus disease in Malaysia. J Infect Dis. 2005;192(Suppl 1):S80–S86.
  • Loganathan T, Ng CW, Lee WS, et al. The hidden health and economic burden of rotavirus gastroenteritis in Malaysia: an estimation using multiple data sources. Pediatr Infect Dis J. 2016;35(6):601–606.
  • Phua KB, Tee N, Tan N, et al. A hospital-based surveillance of rotavirus gastroenteritis in children <5 years of age in Singapore. Pediatr Infect Dis J. 2013;32(12):e426–e431.
  • Lou JT, Xu XJ, Wu YD, et al. Epidemiology and burden of rotavirus infection among children in Hangzhou, China. J Clin Virol. 2011;50(1):84–87.
  • Wang XY, Xu ZY, Von Seidlein L, et al. Incidence of diarrhea caused by rotavirus infections in rural Zhengding, China: prospective, population-based surveillance. J Infect Dis. 2005;192(Suppl 1):S100–S105.
  • Zhang J, Liu H, Jia L, et al. Active, population-based surveillance for rotavirus gastroenteritis in Chinese children: Beijing municipality and Gansu Province, China. Pediatr Infect Dis J. 2015;34(1):40–46.
  • Latipov R, Utegenova E, Kuatbayeva A, et al. Epidemiology and burden of rotavirus disease in Central Asia. Int J Infect Dis. 2011;15(7):e464–e469.
  • Flem ET, Latipov R, Nurmatov ZS, et al. Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in Kyrgyzstan. J Infect Dis. 2009;200(Suppl 1):S195–S202.
  • Hacimustafaoglu M, Celebi S, Agin M, et al. Rotavirus epidemiology of children in Bursa, Turkey: a multi-centered hospital-based descriptive study. Turk J Pediatr. 2011;53(6):604–613.
  • Anh DD, Thiem VD, Fischer TK, et al. The burden of rotavirus diarrhea in Khanh Hoa Province, Vietnam: baseline assessment for a rotavirus vaccine trial. Pediatr Infect Dis J. 2006;25(1):37–40.
  • Zaman K, Yunus M, Faruque AS, et al. Surveillance of rotavirus in a rural diarrhoea treatment centre in Bangladesh, 2000–2006. Vaccine. 2009;27(Suppl 5):F31–F34.
  • Wangchuk S, Dorji T, Tsheten K, et al. A prospective hospital-based surveillance to estimate rotavirus disease burden in Bhutanese children under 5 years of age. Trop Med Health. 2015;43(1):63–68.
  • Bahl R, Ray P, Subodh S, et al. Incidence of severe rotavirus diarrhea in New Delhi, India, and G and P types of the infecting rotavirus strains. J Infect Dis. 2005;192(Suppl 1):S114–S119.
  • Banerjee I, Ramani S, Primrose B, et al. Comparative study of the epidemiology of rotavirus in children from a community-based birth cohort and a hospital in South India. J Clin Microbiol. 2006;44(7):2468–2474.
  • Tate JE, Chitambar S, Esposito DH, et al. Disease and economic burden of rotavirus diarrhoea in India. Vaccine. 2009;27(Suppl 5):F18–F24.
  • Qazi R, Sultana S, Sundar S, et al. Population-based surveillance for severe rotavirus gastroenteritis in children in Karachi, Pakistan. Vaccine. 2009;27(Suppl 5):F25–F30.
  • Carlos CC, Inobaya MT, Bresee JS, et al. The burden of hospitalizations and clinic visits for rotavirus disease in children aged <5 years in the Philippines. J Infect Dis. 2009;200(Suppl 1):S174–S181.
  • Lau YL, Nelson EA, Poon KH, et al. Efficacy, safety and immunogenicity of a human rotavirus vaccine (RIX4414) in Hong Kong children up to three years of age: a randomized, controlled trial. Vaccine. 2013;31(18):2253–2259.
  • Yeung KH, Tate JE, Chan CC, et al. Rotavirus vaccine effectiveness in Hong Kong children. Vaccine. 2016;34(41):4935–4942.
  • Phua KB, Lim FS, Lau YL, et al. Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study. Vaccine. 2009;27(43):5936–5941.
  • Phua KB, Lim FS, Lau YL, et al. Rotavirus vaccine RIX4414 efficacy sustained during the third year of life: a randomized clinical trial in an Asian population. Vaccine. 2012;30(30):4552–4557.
  • Li RC, Huang T, Li Y, et al. Human rotavirus vaccine (RIX4414) efficacy in the first two years of life: a randomized, placebo-controlled trial in China. Hum Vaccin Immunother. 2014;10(1):11–18.
  • Ali Z, Harastani H, Hammadi M, et al. Rotavirus genotypes and vaccine effectiveness from a sentinel, hospital-based, surveillance study for three consecutive rotavirus seasons in Lebanon. PLoS One. 2016;11(8):e0161345.
  • Zaman K, Dang DA, Victor JC, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;376(9741):615–623.
  • Zaman K, Sack DA, Neuzil KM, et al. Effectiveness of a live oral human rotavirus vaccine after programmatic introduction in Bangladesh: a cluster-randomized trial. PLoS Med. 2017;14(4):e1002282.
  • Bhandari N, Rongsen-Chandola T, Bavdekar A, et al. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life. Vaccine. 2014;32(Suppl 1):A110–A116.
  • Jonesteller CL, Burnett E, Yen C, et al. Effectiveness of rotavirus vaccination: a systematic review of the first decade of global post-licensure data, 2006–2016. Clin Infect Dis. 2017;65(5):840–850.
  • Elam-Evans LD, Yankey D, Singleton JA, et al. National, state, and selected local area vaccination coverage among children aged 19–35 months - United States, 2013. MMWR Morb Mortal Wkly Rep. 2014;63(34):741–748.
  • De Oliveira LH, Danovaro-Holliday MC, Matus CR, et al. Rotavirus vaccine introduction in the Americas: progress and lessons learned. Expert Rev Vaccines. 2008;7(3):345–353.
  • De Oliveira LH, Danovaro-Holliday MC, Sanwogou NJ, et al. Progress in the introduction of the rotavirus vaccine in Latin America and the Caribbean: four years of accumulated experience. Pediatr Infect Dis J. 2011;30(1 Suppl):S61–S66.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.